I just saw a newsitem somewhere on internet about the vaccine against Pseudomonas Aeruginosa.
<i>Crucell stopt with the development of a vaccine against Pseudomonas Aeruginosa in patients with Cystic Fibrosis. From tests on 476 patients from four countries, of which a part got a placebo, became clear that Aerugen is insufficiently effective.
Earlier clinical studies showed to be succefull. Aerugen seemed to be able to keep Pseudomonas Aeruginosa away from people with Cystic Fibrosis.
Crucell got the candidate vaccine when they took over Berna Biotech from Switzerland. According to the company the decision has no influence on the income this year.
</i>
I translated it from Dutch, i don't know if there is an article in English somewhere on the net too. The last line isn't really necessary. But i posted it anyway.
Hopefully the next time a company gets another breakthrough it will be succesfull!
<i>Crucell stopt with the development of a vaccine against Pseudomonas Aeruginosa in patients with Cystic Fibrosis. From tests on 476 patients from four countries, of which a part got a placebo, became clear that Aerugen is insufficiently effective.
Earlier clinical studies showed to be succefull. Aerugen seemed to be able to keep Pseudomonas Aeruginosa away from people with Cystic Fibrosis.
Crucell got the candidate vaccine when they took over Berna Biotech from Switzerland. According to the company the decision has no influence on the income this year.
</i>
I translated it from Dutch, i don't know if there is an article in English somewhere on the net too. The last line isn't really necessary. But i posted it anyway.
Hopefully the next time a company gets another breakthrough it will be succesfull!